全球生物可吸收聚合物市场规模（按类型、应用、区域范围、预测）

生物可吸收聚合物的市场规模与预测

2024 年生物可吸收聚合物市场规模为 221.5 亿美元，预计到 2032 年将达到 605.8 亿美元，2026 年至 2032 年的复合年增长率为 13.40%。

生物可吸收聚合物本质上具有生物相容性和水解不稳定性，使其适合用作人体吸收和代谢的植入。

这些聚合物广泛应用于整形外科固定、血管支架、组织工程和控制药物传输等领域。

全球生物可吸收聚合物市场动态

影响生物可吸收聚合物市场的关键市场动态为：

关键市场驱动因素

航空客运量不断增长：心血管疾病发病率的上升推动了对由生物可吸收聚合物製成的生物可吸收支架的需求。根据世界卫生组织 (WHO) 的数据，心血管疾病是全球头号死因，每年约有 1,790 万人死于心血管疾病。这种日益增长的盛行率推动了生物可吸收支架的使用，从而推动了生物可吸收聚合物市场的发展。

严格的安全法规：包括骨折固定和组织工程在内的整形外科手术的扩展，正在推动对生物可吸收聚合物的需求。根据美国整形外科学会的数据，光是在美国，每年就进行约680万例整形外科手术。如此大量的手术推动了生物可吸收聚合物在植入和固定装置中的应用。

制氧系统的技术进步：製药业专注于开发新型药物输送技术，这推动了生物可吸收聚合物市场的发展。根据美国药品研究与工业协会 (PhRMA) 的一项研究，预计到 2022 年，生物製药产业将在研发方面投入约 1,020 亿美元。其中很大一部分投资将用于开发新型药物输送系统，其中许多系统都采用了生物可吸收聚合物。

主要挑战

成本更高：生物可吸收聚合物的价格远高于典型的医用级聚合物，通常每公斤成本超过 2,200 美元。製造成本较高是一个严重的限制因素，尤其是在註重成本效益的应用和价格敏感的市场。

来自不可吸收聚合物的竞争：在某些应用中，人们选择不可吸收聚合物是因为其性能稳定或成本较低。来自成熟不可吸收材料的竞争限制了生物可吸收聚合物市场的成长潜力。

主要趋势：

组织工程应用日益广泛：由于支架设计和细胞培养技术的进步，生物可吸收聚合物在组织工程应用领域的市场正在迅速扩张。随着生物可吸收聚合物在再生医学领域助力组织再生并改善患者预后，预计这一趋势将持续下去。

与先进药物输送系统的整合：在生物可吸收聚合物中引入改进的药物传输系统是一个关键趋势。这使得治疗药物的释放更加精确和可控，从而改善各种药物应用的治疗效果和患者预后。这种整合可能会推动市场成长。

永续包装应用不断拓展：环保包装解决方案的需求日益增长，而生物可吸收聚合物则是长期选择。随着生物分解性、可堆肥的生物可吸收聚合物在包装领域的应用不断拓展，这一趋势预计将持续下去。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章。生物可吸收聚合物市场（按类型）

• 聚乳酸（PLA）
• Polyglycolic（PGA）
• 聚乳酸-乙醇酸共聚物 (PLGA)
• 聚己内酯（PCL）
• 其他的

第五章生物可吸收聚合物市场（依应用）

• 整形外科器械
• 药物输送
• 其他的

第六章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第七章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第八章 竞争态势

• 主要企业
• 市场占有率分析

第九章 公司简介

• Corbion NV（Netherlands）
• Evonik Industries AG（Germany）
• BASF SE（Germany）
• NatureWorks LLC（US）
• Eastman Chemical Company（US）
• Total Corbion PLA（Netherlands）
• Novamont SpA（Italy）
• Ashland Global Holdings Inc.（US）
• Arkema SA（France）
• Boonton Inc.（US）

第十章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十一章 市场展望 附录

• 简称列表
• 来源和参考文献

Bioresorbable Polymers Market Size And Forecast

Bioresorbable Polymers Market size was valued at USD 22.15 Billion in 2024 and is projected to reach USD 60.58 Billion by 2032, growing at a CAGR of 13.40% from 2026 to 2032.

Bioresorbable polymers are intrinsically biocompatible and hydrolytically unstable, making them suitable for use in temporary implants that will be absorbed and metabolized by the human body.

These polymers are widely employed in applications such as orthopedic fixing, vascular stents, tissue engineering, and controlled drug delivery.

Global Bioresorbable Polymers Market Dynamics

The key market dynamics that are shaping the bioresorbable polymers market include:

Key Market Drivers

Increasing Air Passenger Traffic: The rising prevalence of cardiovascular illnesses is pushing up demand for bioresorbable stents constructed from bioresorbable polymers. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death worldwide, killing an estimated 17.9 million people each year. This increasing prevalence encourages the use of bioresorbable stents, which drives the bioresorbable polymers market.

Stringent Safety Regulations: The expanding number of orthopedic procedures, notably fracture fixation and tissue engineering, is driving up demand for bioresorbable polymers. According to the American Academy of Orthopedic Surgeons, around 6.8 million orthopedic surgeries are performed in the United States alone each year. This high volume of treatments encourages the use of bioresorbable polymers in implants and fixation devices.

Technological Advancements in Oxygen Generation Systems: The pharmaceutical industry's emphasis on creating new drug delivery technologies is driving the bioresorbable polymer market. According to a survey from the Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry invested an estimated $102 billion in R&D in 2022. A large percentage of this investment is going into developing novel drug delivery systems, many of which use bioresorbable polymers.

Key Challenges:

Higher Costs: Bioresorbable polymers are substantially more expensive than typical medical polymers, sometimes exceeding $2,200 per kilogram. Higher production costs are a serious constraint, particularly for applications requiring cost-effectiveness or in price-sensitive markets.

Competition from Non-Resorbable Polymers: In some applications, non-resorbable polymers may be selected due to their established performance or cheaper cost. The rivalry from established non-bioresorbable materials limits the bioresorbable polymers market's growth potential.

Key Trends:

Increase in Adoption in Tissue Engineering: The bioresorbable polymers market is expanding rapidly in tissue engineering applications, owing to advances in scaffold design and cell culture techniques. This trend is predicted to continue as bioresorbable polymers help with tissue regeneration and enhance patient outcomes in regenerative medicine.

Integration with Advanced Drug Delivery Systems: The introduction of improved drug delivery systems into bioresorbable polymers is an important trend. This allows for more accurate and controlled therapeutic release, which improves therapy efficacy and patient outcomes in a variety of medicinal applications. This merger is likely to accelerate market growth.

Growing Use in Sustainable Packaging: The demand for environmentally responsible packaging solutions is growing, and bioresorbable polymers offer long-term options. This trend is projected to continue as the market grows to encompass packaging applications for bioresorbable polymers, which are biodegradable and compostable.

Global Bioresorbable Polymers Market Regional Analysis

Here is a more detailed regional analysis of the bioresorbable polymers market:

North America:

According to Verified Market Research, North America is estimated to dominate the bioresorbable polymers market during the forecast period. North America has a high incidence of cardiovascular illness, which is increasing demand for bioresorbable stents and other bioresorbable polymer-based medical devices. According to the American Heart Association's 2023 Heart Disease and Stroke Statistics, approximately 126.9 million adults in the United States have some type of cardiovascular disease. This high incidence is driving the development of innovative medical devices, particularly those that use bioresorbable polymers.

The North American region has a high number of orthopedic procedures, which increases the demand for bioresorbable polymers used in implants and fixation devices. According to the American Academy of Orthopedic Surgeons, about 1 million joint replacements are performed annually in the United States. This large volume of treatments drives the bioresorbable polymers market in the region.

Furthermore, North America, especially the United States, is a leader in healthcare research and development, including the creation of new applications for bioresorbable polymers. According to the National Institutes of Health (NIH), the NIH's legislated budget for FY 2023 was $47.5 billion, with a major amount going toward research involving advanced materials such as bioresorbable polymers. This amount of investment stimulates innovation and market expansion in the bioresorbable polymers market.

Europe:

Europe region is estimated to exhibit the highest growth during the forecast period. Europe's population is aging, which increases the incidence of cardiovascular illnesses and drives up demand for bioresorbable stents. According to Eurostat, the proportion of adults 65 and older in the EU-27 is expected to rise from 20.3% in 2019 to 29.4% by 2050. The European Heart Network states that cardiovascular illnesses kill 3.9 million people in Europe each year, accounting for 45% of all deaths. The demographic shift and illness burden are driving the use of bioresorbable polymers in cardiovascular applications.

The region has an advanced healthcare system encourages the use of breakthrough medical technology, including bioresorbable polymers. The European Federation of National Associations of Orthopedics and Traumatology (EFORT) estimates that more than 7 million orthopedic treatments are performed in Europe each year. The large volume of surgeries, combined with the region's superior healthcare infrastructure, is driving increased demand for bioresorbable polymers in orthopedic applications.

Furthermore, Europe has a strong presence in pharmaceutical and medical device research, which drives innovation in bioresorbable polymers. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical sector invested roughly €39.0 billion in research and development in Europe in 2021. A large percentage of this research is focused on enhanced drug delivery systems and medical devices, many of which include bioresorbable polymers.

Asia Pacific:

The Asia Pacific region is estimated to exhibit substantial growth during the forecast period. The Asia Pacific region is experiencing a large increase in cardiovascular illness, which is increasing the demand for bioresorbable polymer stents. According to the World Health Organization (WHO), cardiovascular illnesses cause 35% of all fatalities in the Western Pacific Region, which covers much of Asia. In China alone, nearly 290 million individuals suffer from cardiovascular disease. This high illness load is driving the introduction of sophisticated medical devices made from bioresorbable polymers.

The increasing number of orthopedic procedures in the Asia Pacific region is driving up demand for bioresorbable polymers used in implants and fixation devices. According to a study published in The Lancet, the number of hip and knee replacement surgeries in Asia is anticipated to rise by 174% from 2015 to 2030. In China, the number of these treatments is expected to reach 1.3 million by 2030. The increase in orthopedic surgeries is propelling the bioresorbable polymers market in the region.

Furthermore, the rapid growth of the pharmaceutical and biotechnology sectors in the Asia Pacific is driving research and development into bioresorbable polymer-based drug delivery systems. According to the India Brand Equity Foundation, the Indian pharmaceutical sector is predicted to grow to $65 billion by 2024. Similarly, the International Trade Administration projects that China's pharmaceutical industry reached $161.8 billion by 2023. This expansion is fueling innovation in medication delivery systems, many of which include bioresorbable polymers.

Global Bioresorbable Polymers Market: Segmentation Analysis

The Global Bioresorbable Polymers Market is segmented based on Type, Application, and Geography.

Bioresorbable Polymers Market, By Type

• Polylactic acid (PLA)
• Polyglycolic acid (PGA)
• Poly(lactic-co-glycolic) acid (PLGA)
• Polycaprolactone (PCL)
• Others

Based on Type, the market is segmented into Polylactic acid (PLA), Polyglycolic acid (PGA), Poly(lactic-co-glycolic) acid (PLGA), Polycaprolactone (PCL), and Others. The polylactic acid (PLA) segment is estimated to dominate the bioresorbable polymers market. PLA is a biodegradable and biocompatible polymer that finds widespread use in medical applications such as sutures, implants, and drug delivery systems. Its high processability, mechanical strength, and biodegradability make it an ideal material for a variety of medical devices and implants.

Bioresorbable Polymers Market, By Application

• Orthopedic Devices
• Drug Delivery
• Others

Based on Application, the market is segmented into Orthopedic Devices, Drug Delivery, and Others. The orthopedic device segment is estimated to dominate the bioresorbable polymers market during the forecast period. The increasing prevalence of orthopedic illnesses, the need for biocompatible medical devices, the number of surgical treatments, and a tendency toward minimally invasive orthopedic procedures all contribute to the rapid expansion of the orthopedics segment. Bioresorbable polymers are especially beneficial in orthopedics because they can give temporary support during the healing process without necessitating further implant removal procedures. This eliminates the difficulties associated with non-resorbable implants.

Bioresorbable Polymers Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Bioresorbable Polymers market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate the bioresorbable polymers market during the forecasted period due to a high degree of technological expertise in the healthcare industry, particularly in the United States and Canada, as well as high healthcare spending, a significant presence of medical device makers, and the region's increasing frequency of orthopedic illnesses.

Key Players

• The "Bioresorbable Polymers Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Corbion N.V., Evonik Industries AG, BASF SE, NatureWorks LLC, Eastman Chemical Company, Total Corbion PLA, Novamont S.p.A., Ashland Global Holdings, Inc., Arkema SA, and Boonton, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Bioresorbable Polymers Market Recent Developments
• In March 2021, Ashland Global Holdings Inc. extended its Viatel bioresorbable polymer production line and transferred R&D from Dublin to Mullingar's National Science Park.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bioresorbable Polymers Market, By Type

• Polylactic acid (PLA)
• Polyglycolic acid (PGA)
• Poly(lactic-co-glycolic) acid (PLGA)
• Polycaprolactone (PCL)
• Others

5. Bioresorbable Polymers Market, By Application

• Orthopedic Devices
• Drug Delivery
• Others

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Corbion N.V. (Netherlands)
• Evonik Industries AG (Germany)
• BASF SE (Germany)
• NatureWorks LLC (US)
• Eastman Chemical Company (US)
• Total Corbion PLA (Netherlands)
• Novamont S.p.A. (Italy)
• Ashland Global Holdings Inc. (US)
• Arkema SA (France)
• Boonton Inc. (US)

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References